The paper, published May 7, 2018 in the Journal of Psychopharmacology, shows evidence that harmful long-term effects of MDMA are probably caused by very high doses that most people don’t actually take. -Study’s authors were led by Balázs Szigeti, a Ph.D. candidate at the University of Edinburgh, In the Global Drug Survey, which includes recreational ecstasy use data…
The study, led by UC Davis chemist David E. Olson, was published Tuesday, June 12th, in the journal Cell Reports. The discovery of this neurite-promoting property could shed light on why these chemically distinct drugs all appear helpful in treating depression, anxiety, addiction and post-traumatic stress disorder, or PTSD, Olson said. In test tubes as well as…
White says a way forward for kratom may involve treating it like an over-the-counter medication such as pseudoephedrine, which require patients to consult with a pharmacist about interactions and health issues. For now, though, the FDA maintains that clinical trials should form the basis of any policy that regulates kratom. The agency doesn’t seem to…
“Since kratom can be grown in your backyard, pharmaceutical companies can’t monopolize it — unless the government outlaws it.” HERE “They (the FDA) kind of cast aside some of the scientific literature that actually models or observed it in actual receptors,” he says. According to Grundmann, that research shows that although kratom binds to opioid…
“There’s a very big obsession, I would say, in the field of getting rid of the addictive properties, but I think what we should focus on is just not killing people to start with [HERE]. If you get rid of respiratory depression [caused by traditional and synthetic opiates], you’re saving 18,000 lives a year from…
The first reports of pharmacological studies on mitragynine appeared in the literature in 1972 (Macko et al., 1972). Researchers at Smith, Kline, and French (SKF) were interested in finding a novel analgesic that would have less liability than the currently utilized opioids (i,e. morphine). Their studies were the most comprehensive at the time and still…
More than 50 leading kratom vendors and advocacy groups gathered to discuss the future of kratom in America at the first Kratom Leadership Summit on Monday, April 30, 2018. Henningfield told attendees that the FDA and those fighting to ban kratom are misguided in their understanding of the plant’s effects and its purported opioid-like qualities.…
At the outset of the study, 27 professionals from various fields were given three tests which objectively measure creativity … Several days later they took the tests again. Except this time they were under the influence of 200mgs of mescaline. Their scores improved dramatically … Creativity drives societal and technological progress. Psychedelics markedly increase creativity.…
*images not intended for use as an identification guide Like a May shower, the studies on psychedelic drugs’ potential therapeutic benefits came — first as a sprinkle, then a steady downpour. …that spate of published research on psychedelics now seems to be leading to the development some promising potential treatments … [In 2017] researchers studying…
By imposing an effective ban on importing kratom (including seizures at ports), the FDA forced manufacturers to shift from high-quality sources of the herb to lesser suppliers, thus increasing the potential for issues such as salmonella, which had never previously been an issue with kratom in the U.S. The U.S. Food and Drug Administration (FDA)…
Recent Comments